[On the induction of an active chronic hepatitis by heterologic soluble liver proteins].
D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000276:immunology; D002845:Chromatography; D002908:Chronic Disease; D005455:Fluorescent Antibody Technique; D006505:Hepatitis / Q000209:etiology; D006520:Hepatitis, Animal; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced / Q000150:complications; D006969:Hypersensitivity, Immediate; D007108:Immune Tolerance; D008099:Liver / Q000276:immunology / Q000473:pathology; D008110:Liver Extracts / Q000494:pharmacology*; D008214:Lymphocytes / Q000473:pathology; D008722:Methods; D011506:Proteins / Q000494:pharmacology; D011817:Rabbits; D013154:Spleen / Q000473:pathology; D014461:Ultracentrifugation
D001323:Autoantibodies; D008110:Liver Extracts; D011506:Proteins
Zur Induktion einer aktiven chronischen Hepatitis durch heterologe lösliche Leberproteine.